SNGSF yields 11.90% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, SNGSF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SNGSF + JNJ for your $10,000?
Singamas Container Holdings Limited, an investment holding company, manufactures and sells containers and other related products. It operates in two segments, Manufacturing and Logistics Services. The Manufacturing segment manufactures dry freight containers, collapsible flat rack containers, tank containers, U.S. domestic containers, offshore containers, open top containers, bitutainers, and other specialized containers and container parts. The Logistics Services segment provides container storage, repair, trucking, container/cargo handling, and other container related services; and serves as a freight station. It operates eight container depots, including seven at Dalian, Tianjin, Qingdao, Shanghai, Ningbo, Fuzhou, and Xiamen ports. The company also provides drayage, dry freight manufacturing, container leasing, management, mid-stream, property holding, and human resource management services. It operates in the United States, Korea, Hong Kong, Singapore, Europe, the People's Republic of China, the Middle East, Taiwan, and internationally. The company was incorporated in 1988 and is based in Central, Hong Kong.
Full SNGSF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.